The Risk Appraisal Forum has been able attract some of the key medical researchers and physicians from around the country as speakers.   Advances in medical research and technological breakthroughs are occurring at an ever-accelerating pace.   New discoveries, shifts in paradigms, and advances in treatments are an essential part of our medical system.   The Risk Appraisal Forum has developed a platform for the practicing and research community to share these advances with the life insurance community.   Your presentation could be instrumental in helping families obtain the vital life insurance protection that they need.   The Risk Appraisal Forum brings together many of the key underwriting decision makers and policy setters within the medical  underwriting community.  They have the clout to make bold changes which can impact industry-wide underwriting guidelines.   Together it’s a wonderful combination!  Your presentation could eventually one day help one of your patients to obtain the life insurance that he or she needs.

Frequently Asked Questions:

Q: I’m used to talking to other medical colleagues.  Do I have to bring the content and language “down” for this group?

The group will consists of fellow physicians (medical directors),  executives in the underwriting departments, underwriters, and RAF members.   Besides the medical directors, the audience will have an above average medical knowledge.   There will be no need to bring “down” your presentation or to spend time explaining the basics of a certain conditions, diseases, procedures, or treatments.

Q: What areas of my research or specialty should I focus on?

The group’s primary interest is focused on how your research or specialty can affect the medical  community’s thinking on the specific disease or condition.   The life insurance underwriter’s and medical director’s interest is centered around how mortality experience could be improved or could be diminished based on the results of the current studies, new technologies, or cutting-edge research.  Presentations that focus on end-stage diseases would have little relevance for this group.  For example, being able to extend a patient’s life expectancy from a few weeks to a year, while important, would not be of great relevance from a medical underwriting standpoint.

Q: How long should the presentation be?

The presentation should be 45 minutes to 1 hour and then about 15 minutes for questions.

Q: How many people will be in attendance?

There are usually between 30 to 45 people that are at the presentations.

Q: Is there an honorarium or fee for making the presentation?

Most of the presenters have waived any type of honorarium or fee for making the presentation.  The importance of getting your information to some of the key people in the life insurance industry is of the essence.   Since this is a study group, the funds are limited.